SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq:RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that the Company will host investor meetings at the Wells Fargo Healthcare Conference, and present and host meetings at the H.C. Wainwright 25th Annual Global Investor Conference.
Read more at prnewswire.comRegulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)
